The Biden administration announced on Friday an agreement to purchase 100,000 doses of the Eli Lilly monoclonal antibody cocktail, which was recently authorized by the U.S. Food and Drug Administration (FDA).
This move will increase the available supply of one of the few proven treatments for COVID-19 patients. The antibody drug has been authorized for patients who are at high risk of serious illness but have not yet been hospitalized.
According to the agreement, the federal government will pay 210 million U.S. dollars for the initial purchase of up to 100,000 courses of therapeutic drugs. The drug is a combination of bamlanivimab approved for high-risk COVID-1
Combination obtains emergency use authorization Early this monthAccording to data, this method can reduce the risk of hospitalization and death by 70%.
The agreement includes the flexibility to purchase up to 1.2 million doses by November, but this may depend on the course of the pandemic in the coming months.
The government has pledged to purchase only 14.5 million doses of pannibizumab, including one million doses, and agreed to deliver another 450,000 doses by the end of March.
The government said it will provide neutralizing antibodies to patients for free, although medical institutions may charge a fee for the management of the product.
To receive antibody therapy, patients should contact their healthcare provider.
Another antibody treatment method produced by Regeneron has also been authorized by the FDA. Regeneron is providing up to 1.5 million doses to the federal government.
But despite the effectiveness of antibody therapy and the federal government encourages its use, the demand for antibody therapy is sluggish.
First, the supply is limited, and ensuring the delivery of drugs to patients is a complex task. Since they are infusion drugs, they need to be administered in an appropriate environment. The dosing window is small, and patients need to be diagnosed quickly.
It is very difficult to transport patients to infusion centers or hospitals, especially due to the uncontrollable pandemic that puts tremendous pressure on hospitals and medical staff. Experts call for a better system to ensure that drugs reach the patients who need them most.
Monoclonal antibody therapy was widely publicized when it was given to the former last fall President TrumpDonald Trump (Donald Trump Jr.) called Bruce Springsteen’s withdrawal of charges a “privilege of freedom.”Schiff believes that the Intel committee is facing challenges, and McConnell, a community in Trump’s shadow, said that he will support Trump as the nominee for the GOP in 2024. More When he was infected last fall.
He also provided treatment to well-known Republicans and Trump allies, such as his personal lawyer. Rudy GiulianiMyPillow CEO Rudy Giuliani MyPillow said that the boycott has made him target MyPillow’s Mike Lindell with M.Dominion with a .3B defamation lawsuit. Despite the acquittal of the Senate, Trump’s legal troubles may not be over, The former governor of New Jersey. Chris ChristieThe aftermath of Chris Christie Cancun threatens to cause lasting damage to Cruz On the Trail: The Supreme Court clears the political dangers of former Snowmageddon Ex-Christie aides to campaign “Bridge Gate” scandal campaigns for local office And the former Minister of Housing and Urban Development Ben CarsonBen Carson (Ben Carson) Ben Carson (Ben Carson) launched the conservative think tank Trump (MLK Day) released Trump “1776 report” is strongly opposed.